Our Research
Our Research
Pipeline
Pipeline
We are a research-driven biotech company dedicated to the discovery of first-in-class therapies addressing unmet needs. Our platforms and portfolio deliver NCEs and protein therapeutics against novel targets of relevance in oncology and neurodegeneration.
Research Pipelines
Ubi-Plex® DUB Platform
These have revolutionised the treatment of previously intractable conditions such as multiple myeloma.
Find out more
Protein Drug Conjugates
With the approvals of antibody-drug conjugates, such as Kadcyla®, Adcetris® and Besponsa®, and an increasing number of ADCs entering…
Find out more